Načítá se...
Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
INTRODUCTION: There are no empiric data to support guidelines for duration of therapy with antidementia drugs. This study examined whether persistent use of antidementia drugs slows clinical progression of Alzheimer disease (AD) assessed by repeated measures on serial tests of cognition and function...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2874259/ https://ncbi.nlm.nih.gov/pubmed/19845950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|